BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8456099)

  • 1. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis.
    Dennis MS; Carter P; Lazarus RA
    Proteins; 1993 Mar; 15(3):312-21. PubMed ID: 8456099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification, and characterization of recombinant ornatin E, a potent glycoprotein IIb-IIIa antagonist.
    Mazur P; Dennis MS; Seymour JL; Lazarus RA
    Protein Expr Purif; 1993 Aug; 4(4):282-9. PubMed ID: 8374297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential 1H NMR assignments of kistrin, a potent platelet aggregation inhibitor and glycoprotein IIb-IIIa antagonist.
    Adler M; Wagner G
    Biochemistry; 1992 Feb; 31(4):1031-9. PubMed ID: 1734953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S; Flynn G; Aitken A; Patel Y; Hussain F; Lu X; Loftus JC; French D; Wijelath E; Strand K; Savidge GF
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex.
    Andrews RK; Harris SJ; McNally T; Berndt MC
    Biochemistry; 1998 Jan; 37(2):638-47. PubMed ID: 9425086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist.
    Adler M; Lazarus RA; Dennis MS; Wagner G
    Science; 1991 Jul; 253(5018):445-8. PubMed ID: 1862345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.
    Dennis MS; Henzel WJ; Pitti RM; Lipari MT; Napier MA; Deisher TA; Bunting S; Lazarus RA
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2471-5. PubMed ID: 2320569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ornatins: potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata.
    Mazur P; Henzel WJ; Seymour JL; Lazarus RA
    Eur J Biochem; 1991 Dec; 202(3):1073-82. PubMed ID: 1765068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function.
    McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S
    Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold.
    Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R
    Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence.
    Jing J; Lu S
    Biotechnol Lett; 2005 Sep; 27(17):1259-65. PubMed ID: 16215822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.
    Bayer AS; Sullam PM; Ramos M; Li C; Cheung AL; Yeaman MR
    Infect Immun; 1995 Sep; 63(9):3634-41. PubMed ID: 7642301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist.
    Wang WJ; Huang TF
    Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet-vessel wall interaction. Platelet receptors, monoclonal antibodies, and synthetic peptides.
    Ruggeri ZM
    Circulation; 1990 Jan; 81(1 Suppl):I35-9; discussion I40-1. PubMed ID: 2403866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation.
    Rahman S; Aitken A; Flynn G; Formstone C; Savidge GF
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):247-57. PubMed ID: 9761721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.